Interspecies Pharmacokinetics of a Novel Hematoregulatory Peptide (SK&F 107647) in Rats, Dogs, and Oncologic Patients

Pharmaceutical Research

Volumn 13, Issue 5, 1996, Pages 794-797

  Brocks, Dion R ^a,d   Freed, Martin I ^a   Martin, David E ^a   Sellers, Teresa S ^a   Mehdi, Nabeel ^b   Citerone, David R ^a   Boppana, Venkata ^a   Levitt, Blanche ^a   Davies, Brian E ^a   Nemunaitis, John ^c   Jorkasky, Diane K ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Nycomed Hafslund Pharma AG   (Austria)

^c TEXAS ONCOLOGY   (United States)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Allometric scaling; Hematology; Infection; Peptide; Pharmacokinetics

Indexed keywords

PENTAPEPTIDE; SFK 107647; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PHARMACOKINETICS; PHASE 1 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

ADJUVANTS, IMMUNOLOGIC; AGED; ANIMALS; DOGS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY;

EID: 0029937144     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016020221300     Document Type: Article

References (14)

1. J. Mordenti and W. Chappell. The use of interspecies scaling in toxicokinetics. In A. Yacobi, J. Skelly, and V. Batra (eds), Toxicokinetics and New Drug Development, Permagon. New York, 1989, pp. 42-96.
2. W. R. Chappell and J. Mordenti. Extrapolation of toxicological and pharmacological data from animals to humans. Adv. Drug Res. 20:1-116 (1991).
3. J. Mordenti, S. A. Chen, J. A. Moore, B. L. Ferraiolo, and J. D. Green. Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins. Pharm. Res. 8:1351-1359 (1991).
4. J. Hysing, J. O. Gordelad, G. Christensen, and H. Tolleshaug. Renal uptake and degradation of trapped-label calcitonin. Biochem. Pharmacol. 41:1119-1126 (1991).
5. T. Maack, C. H. Park, and M. J. F. Gamaro. Renal filtration, transport, and metabolism of proteins. In D. W. Seldin and G. Giesbisch (eds), The kidney, physiology and pathophysiology, 2nd edition, New York, Marcel Dekker, 1992, pp. 3005-3038.
6. T. Maack, V. Johnson, S. T. Kau, J. Figueiredo, and D. Sigulem. Renal filtration, transport, and metabolism of low-molecular weight proteins. Kidney Int. 16:251-270 (1979).
7. C. A. Elder, and M. W. Modi. Interspecies scaling of a thienodiazepine platelet-activating factor receptor antagonist. Drug Melabol. Dispos. 23:776-778 (1995).
8. J. H. Lin. Species similarities and differences in pharmacokinetics. Drug Metabol. Dispos. 23:1008-1021 (1995).
9. L. M. Pelus, A. G. King, H. E. Broxmeyer, P. L. DeMarsh, S. R. Petteway, and P. Bhatnagar. In vivo modulation of hematopoiesis by a novel hematoregulatory peptide. Exp. Hematol. 22:239-247 (1994).
10. V. K. Boppana, and C. Miller-Stein. Determination of a novel hematoregulatory peptide in dog plasma by reversed-phase high performance liquid chromatography and an amine-selective o-phthaldehyde-thiol post-column reaction with fluorescence detection. J. Chromatogr. 676:161-167 (1994).
11. D. W. Cockcroft, M. H. Gault. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41 (1976).
12. G. D. Allen. MODFIT: A pharmacokinetics computer program. Biopharm. Drug Dispos. 10:477-498 (1990).
13. B. Davies and T. Morris. Physiological parameters in laboratory animals and humans. Pharm. Res. 10:1093-1095 (1993).
14. S. Shargel, and A. B. C. Yu. Applied biopharmaceutics and pharmacokinetics. ACC, Norwalk, 1985.